Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 11.843\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) O=C(Nc1ccccn1)c1cccc(S(=O)(=O)N2CCCC2)c1
b.) CC1CCN(c2ccc3nnc(CCC(=O)NC(C)C)n3n2)CC1
c.) c1ccc(Cc2nnc3sc(-c4ccncc4)nn23)cc1
d.) Cn1nnnc1SCC(=O)N1CCc2ccccc21
Answer: b. CC1CCN(c2ccc3nnc(CCC(=O)NC(C)C)n3n2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(c2ccc3nnc(CCC(=O)NC(C)C)n3n2)CC1
CC1CCN(c2ccc3nnc(CCC(=O)NC(C)C)n3n2)CC1
3-[6-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-N-propan-2-ylpropanamide